Literature DB >> 6430064

Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease.

S Chatterjee, P Gupta, R E Pyeritz, P O Kwiterovich.   

Abstract

Although the accumulation of neutral glycosphingolipid (GSL), principally globotriaosylceramide ( GbOse3Cer ), in the kidney of patients with Fabry's disease is well documented, little is known about the type and quantity of lipid present in the renal tubular cells shed in the urine. Using a variety of cytologic technics, the authors examined exfoliated cells found in the urine specimens of patients hemizygous and heterozygous for alpha-galactosidase A deficiency. Renal tubular cells contained periodic acid- Shiff positive material that could be identified easily by Papanicolaou stain. A fluorescein-labeled antibody specific for GbOse3Cer localized this lipid to the cytoplasm. Electron microscopy showed numerous electron-dense multilamellar membranous inclusions within phagolysosomes and electronlucent material within lysosomes of tubular cells. Based on immunofluorescence, heterozygote individuals had similar distribution but less quantity of cytoplasmic GSL. The authors conclude that in Fabry's disease GSL accumulates probably in lysosomes of renal tubular cells. These cells are exfoliated and can be identified specifically in voided urine specimens. Examination of renal tubular cells in urine using the fluorescein antibody technic described here affords a noninvasive means of diagnosing and following the effect of therapy in patients with Fabry's disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430064     DOI: 10.1093/ajcp/82.1.24

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.

Authors:  Ladislav Kuchař; Befekadu Asfaw; Helena Poupětová; Jitka Honzíková; František Tureček; Jana Ledvinová
Journal:  Clin Chim Acta       Date:  2013-07-06       Impact factor: 3.786

2.  Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

Authors:  R Schiffmann; G J Murray; D Treco; P Daniel; M Sellos-Moura; M Myers; J M Quirk; G C Zirzow; M Borowski; K Loveday; T Anderson; F Gillespie; K L Oliver; N O Jeffries; E Doo; T J Liang; C Kreps; K Gunter; K Frei; K Crutchfield; R F Selden; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  L&H variants of Reed-Sternberg cells express sialylated Leu M1 antigen.

Authors:  S M Hsu; Y S Ho; P J Li; J Monheit; H J Ree; K Sheibani; C D Winberg
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

4.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

5.  Monitoring enzyme replacement therapy in Fabry disease--role of urine globotriaosylceramide.

Authors:  P D Whitfield; J Calvin; S Hogg; E O'Driscoll; D Halsall; K Burling; G Maguire; N Wright; T M Cox; P J Meikle; P B Deegan
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Low frequency of Fabry disease in patients with common heart disease.

Authors:  Raphael Schiffmann; Caren Swift; Nathan McNeill; Elfrida R Benjamin; Jeffrey P Castelli; Jay Barth; Lawrence Sweetman; Xuan Wang; Xiaoyang Wu
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.864

7.  Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.

Authors:  Raphael Schiffmann; Sabrina Forni; Caren Swift; Nastry Brignol; Xiaoyang Wu; David J Lockhart; Derek Blankenship; Xuan Wang; Paul A Grayburn; Matthew R G Taylor; Brian D Lowes; Maria Fuller; Elfrida R Benjamin; Lawrence Sweetman
Journal:  J Am Heart Assoc       Date:  2014-02-04       Impact factor: 5.501

Review 8.  Biomarkers of Fabry Nephropathy: Review and Future Perspective.

Authors:  Tina Levstek; Bojan Vujkovac; Katarina Trebusak Podkrajsek
Journal:  Genes (Basel)       Date:  2020-09-18       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.